文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

骨矿化:正常和病理情况下从组织到晶体。

Bone mineralization: from tissue to crystal in normal and pathological contexts.

机构信息

Endocrine Center, Austin Health, University of Melbourne, Melbourne, Australia.

出版信息

Osteoporos Int. 2013 Aug;24(8):2153-66. doi: 10.1007/s00198-012-2228-y. Epub 2012 Dec 11.


DOI:10.1007/s00198-012-2228-y
PMID:23229470
Abstract

Bone is a complex and structured material; its mechanical behavior results from an interaction between the properties of each level of its structural hierarchy. The degree of mineralization of bone (bone density measured at tissue level) and the characteristics of the mineral deposited (apatite crystals) are major determinants of bone strength. Bone remodeling activity acts as a regulator of the degree of mineralization and of the distribution of mineral at the tissue level, directly impacting bone mechanical properties. Recent findings have highlighted the need to understand the underlying process occurring at the nanostructure level that may be independent of bone remodeling itself. A more global comprehension of bone qualities will need further works designed to characterize what are the consequences on whole bone strength of changes at nano- or microstructure levels relative to each other.

摘要

骨骼是一种复杂而有结构的材料;其力学性能源于其结构层次中各个层次的特性相互作用的结果。骨骼的矿化程度(组织水平上测量的骨密度)和沉积矿物质的特性(磷灰石晶体)是决定骨强度的主要因素。骨骼重塑活动作为矿化程度和组织水平上矿物质分布的调节剂,直接影响骨骼的力学性能。最近的研究结果强调了需要了解在纳米结构水平上发生的潜在过程,该过程可能与骨骼重塑本身无关。为了更全面地了解骨骼特性,需要进一步研究,以确定纳米或微观结构水平上的变化相对于彼此对整个骨骼强度的影响。

相似文献

[1]
Bone mineralization: from tissue to crystal in normal and pathological contexts.

Osteoporos Int. 2012-12-11

[2]
The mineralization of bone tissue: a forgotten dimension in osteoporosis research.

Osteoporos Int. 2003

[3]
Bone quality--the material and structural basis of bone strength and fragility.

N Engl J Med. 2006-5-25

[4]
Causes of age-related bone loss and bone fragility: an alternative view.

J Bone Miner Res. 2001-11

[5]
[Many issues about bone quality].

Clin Calcium. 2012-6

[6]
[Anisotropic crystallization of biominerals].

Clin Calcium. 2014-2

[7]
Changes in bone remodeling rate influence the degree of mineralization of bone which is a determinant of bone strength: therapeutic implications.

Adv Exp Med Biol. 2001

[8]
[Bone mineralization and mineral status].

Therapie. 2003

[9]
Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease.

Endocr Rev. 2007-4

[10]
The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management.

Clin Ther. 2005-1

引用本文的文献

[1]
Ageing-Related Changes in Ultrastructural Bone Matrix Composition and Osteocyte Mechanosensitivity.

Curr Osteoporos Rep. 2025-8-12

[2]
Canola Protein Hydrolysates Show Osteogenic Activity in MC3T3-E1 Cells.

J Food Sci. 2025-4

[3]
Bone Defect Treatment in Regenerative Medicine: Exploring Natural and Synthetic Bone Substitutes.

Int J Mol Sci. 2025-3-27

[4]
Improvement of bone properties in children with osteogenesis imperfecta after pamidronate: a bone biopsy study.

JBMR Plus. 2024-12-11

[5]
On the influence of structural and chemical properties on the elastic modulus of woven bone under healing.

Front Bioeng Biotechnol. 2024-10-1

[6]
Advances in graphene-based 2D materials for tendon, nerve, bone/cartilage regeneration and biomedicine.

iScience. 2024-6-8

[7]
Understanding Matrix Stiffness in Vinyl Polymer Hydrogels: Implications in Bone Tissue Engineering.

ACS Omega. 2024-3-25

[8]
Understanding formation processes of calcareous nephrolithiasis in renal interstitium and tubule lumen.

J Cell Mol Med. 2024-4

[9]
Bone turnover and mineralisation kinetics control trabecular BMDD and apparent bone density: insights from a discrete statistical bone remodelling model.

Biomech Model Mechanobiol. 2024-6

[10]
Three-dimensional evaluation of condylar morphology after orthodontic treatment in adult patients with Class II malocclusion by cone-beam computed tomography.

BMC Oral Health. 2024-1-8

本文引用的文献

[1]
Effects of strontium on the quality of bone apatite crystals: a paired biopsy study in postmenopausal osteoporotic women.

Osteoporos Int. 2012-10-30

[2]
Bone micromechanical properties are compromised during long-term alendronate therapy independently of mineralization.

J Bone Miner Res. 2012-4

[3]
Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures.

J Bone Miner Res. 2012-3

[4]
Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjects.

Bone. 2011-9-18

[5]
Modifications of bone material properties in postmenopausal osteoporotic women long-term treated with alendronate.

Eur J Endocrinol. 2011-8-5

[6]
Respective roles of organic and mineral components of human cortical bone matrix in micromechanical behavior: an instrumented indentation study.

J Mech Behav Biomed Mater. 2011-5-17

[7]
Bisphosphonates do not alter the rate of secondary mineralization.

Bone. 2011-5-18

[8]
Greater tissue mineralization heterogeneity in femoral neck cortex from hip-fractured females than controls. A microradiographic study.

Bone. 2011-3-21

[9]
Fragility fractures in men with idiopathic osteoporosis are associated with undermineralization of the bone matrix without evidence of increased bone turnover.

Calcif Tissue Int. 2011-2-12

[10]
Methods for assessing bone quality: a review.

Clin Orthop Relat Res. 2011-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索